ArticleScientific reports2025
Plasma copolymerized oxazoline and fluoro monomer based amphiphilic coatings for antibacterial and antifouling applications.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incorporation of antibacterial and antibiofouling properties into commercial fabrics is an attractive proposition considering its multifold applications in the health industry. However poor bacterial anti adhesion and low shelf-life limit their widespread applicability. Moreover, while antifouling at the liquid-solid can be addressed by hydrophilic properties, that at the air-solid interface demands hydrophobicity. This work reports the use of an indigenously developed low pressure plasma set-up to deposit amphiphilic coatings through simultaneous deposition of poly(2-ethyl-2-oxazoline) (2E2O) and 1 H,1 H,2 H,2 H-perfluorodecyl acrylate (PFDA). Plasma parameters: deposition time, power, gas and monomer flow rates were optimized and the samples characterized using FTIR, XPS, SEM-EDX, AFM and Contact Angle (CA) measurement techniques. Samples were observed to inhibit biofilm formation from the viable cell enumeration method, while their biocidal efficacy was also established through antibacterial tests performed as per ISO 22196:2011. These hybrid coatings have potential applications in the healthcare sector as efficient antibacterial and antibiofouling surfaces.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.